Masiá, M., Padilla, S., García, J. A., García-Abellán, J., Navarro, A., Guillén, L., . . . Gutiérrez, F. (2021). Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19. Frontiers Media S.A.
Chicago Style (17th ed.) CitationMasiá, Mar, et al. Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationMasiá, Mar, et al. Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.